[Answered] Pertaining to death of tissues: A) cryotherapy B) melanosis C) necrosis D) ...

This topic contains a solution. Click here to go to the answer

Author Question: Pertaining to death of tissues: A) cryotherapy B) melanosis C) necrosis D) ... (Read 20 times)

cmoore54

Hero Member
Posts: 568

on: Jun 26, 2018

Pertaining to death of tissues:
A) cryotherapy
B) melanosis
C) necrosis
D) metastasis

Question 2

Which condition involves a malignant tumor of one or both testes?
A) balanitis
B) prostate cancer
C) hypospadias
D) testicular carcinoma

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

SeanoH09

Sr. Member
Posts: 323

Reply #1 on: Jun 26, 2018

Answer to Question 1

C

Answer to Question 2

D

cmoore54

Member
Posts: 568

Reply 2 on: Jun 26, 2018

YES! Correct, THANKS for helping me on my review

cdmart10

Member
Posts: 332

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.